Schedule 13G ownership disclosure

ACASTI PHARMA INC

Security class unavailable · CUSIP: 00430K865

Event date: 2024-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
959,571
Percent of class
10.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-079033
Form type
SC 13G
Filer
ADAR1 Capital Management, LLC
CIK
CIK 1940272
Filed
Jul 10, 2024
Reporting period
Jun 28, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub